Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2639641017 | Fluocinolone + neomycin (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 2643641013 | Fluocinolone + neomycin | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 2693151012 | Fluocinolone + Neomycin | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3523394015 | Product containing fluocinolone and neomycin (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3523395019 | Fluocinolone and neomycin | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3523396018 | Product containing fluocinolone and neomycin | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3668447012 | Fluocinolone and neomycin product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3714893011 | Fluocinolone- and neomycin-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fluocinolone- and neomycin-containing product | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
| Fluocinolone- and neomycin-containing product | Is a | Fluocinolone-containing product | true | Inferred relationship | Some | ||
| Fluocinolone- and neomycin-containing product | Is a | Compound neomycin preparations | false | Inferred relationship | Some | ||
| Fluocinolone- and neomycin-containing product | Has active ingredient | Neomycin | true | Inferred relationship | Some | 1 | |
| Fluocinolone- and neomycin-containing product | Has active ingredient | Fluocinolone | true | Inferred relationship | Some | 2 | |
| Fluocinolone- and neomycin-containing product | Is a | Fluocinolone in topical dosage form | false | Inferred relationship | Some | ||
| Fluocinolone- and neomycin-containing product | Is a | Neomycin in topical dosage form | false | Inferred relationship | Some | ||
| Fluocinolone- and neomycin-containing product | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Fluocinolone- and neomycin-containing product | Is a | Neomycin-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fluocinolone- and neomycin-containing product in cutaneous dose form | Is a | True | Fluocinolone- and neomycin-containing product | Inferred relationship | Some | |
| Fluocinolone and neomycin only product | Is a | True | Fluocinolone- and neomycin-containing product | Inferred relationship | Some | |
| Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream | Is a | False | Fluocinolone- and neomycin-containing product | Inferred relationship | Some | |
| Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous ointment | Is a | False | Fluocinolone- and neomycin-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR